查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1820349

2025 年至 2033 年吸入麻醉市場規模、佔有率、趨勢及預測（按產品、應用、最終用戶和地區）

Inhalation Anesthesia Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

2024年，全球吸入麻醉市場規模達16.8億美元。展望未來， IMARC Group預計到2033年，市場規模將達到22億美元，2025-2033年期間的複合年成長率（CAGR）為2.75%。目前，北美佔據市場主導地位，2024年的市佔率將達到52.8%。患有慢性疾病的人數不斷增加，以及製藥公司、醫療器材公司和醫療機構之間的合作，正在推動市場向前發展。此外，政府和私人醫療機構對先進設備的投資不斷增加，也推動了吸入麻醉市場佔有率的成長。

政府加大對醫療機構的投資，提升了外科護理和現代麻醉技術的可近性。新建醫院和外科中心的建設提高了先進吸入麻醉系統的普及率。發展中國家麻醉師訓練計畫促進了安全有效麻醉劑的普及。印度和泰國等國醫療旅遊業的蓬勃發展，增加了吸入麻醉服務的需求。新興市場先進的外科手術增加了七氟醚和地氟醚等現代麻醉劑的使用。醫療保險覆蓋範圍的擴大提高了吸入麻醉外科治療的可負擔性和可近性。醫療計畫中的公私合作 (PPP) 模式促進了先進麻醉技術在醫療資源匱乏地區的整合。

創新麻醉機能夠在手術過程中精確監測和控制吸入麻醉劑的輸送。七氟醚等藥物的藥物動力學改進可實現快速誘導和術後恢復。麻醉機中的整合軟體系統可提高工作流程效率並降低人為失誤的風險。非侵入式監測技術可確保即時回饋病患生命徵象，進而最佳化麻醉給藥並保障病患安全。攜帶式和緊湊型麻醉設備在門診和門診手術中心的應用日益廣泛。環保麻醉劑的開發減少了傳統吸入性麻醉劑對環境的影響。兒科和老年麻醉技術的進步滿足了弱勢族群的特殊醫療保健需求。遠距醫療和遠端監控工具為醫療資源匱乏地區和農村地區的麻醉護理提供支援。麻醉計劃中人工智慧 (AI) 的整合有助於實現個人化給藥和預測患者結果模型。 2024年5月，Panoramic Health在佛羅裡達州坦帕市啟用了一家先進的門診手術中心（ASC）。新中心旨在為各種醫療程序提供高品質、高效的門診手術服務。該中心配備了最新技術，確保手術的精準性、安全性，並改善患者的治療效果。

吸入麻醉市場趨勢：

麻醉劑和輸送系統的不斷進步

製藥公司和醫療器材製造商正大力投資研發，以創造更有效、更安全的麻醉氣體和蒸氣。這些創新旨在透過降低不良反應風險和改善整體麻醉體驗來提高患者的治療效果。正在開發的新型麻醉藥物具有更優的藥物動力學特性，可以更快地誘導和甦醒麻醉，從而縮短患者在手術室中停留的時間。最常使用的全身麻醉誘導藥物是丙泊酚（1 至 2.5 mg/kg，靜脈注射）。此外，包括精密霧化器和監測技術在內的先進輸送系統的發展，確保了麻醉劑的準確給藥和滴定，最大限度地減少了劑量過量或不足的可能性。這些進步不僅有助於改善患者護理，也吸引了醫療機構採用這些現代化的解決方案，從而推動了吸入麻醉市場的成長。

外科手術數量和病人數量的增加

人口成長通常與老化有關，這需要增加外科手術的數量。老年人通常需要進行更多的手術，例如心臟病、關節置換和癌症治療。包括骨科、心臟科、腫瘤科和一般外科在內的外科專科都需要吸入麻醉進行手術。吸入麻醉成為這些干預措施的首選，因為它能夠產生即時且可控的鎮靜深度。因此，它能夠在患者的無意識狀態和生命徵象的穩定之間取得平衡。此外，醫學知識和技術的發展也擴展了外科手術的範圍。根據美國國立衛生研究院 2022 年的數據，53% 的外科手術患者年齡在 65 歲或以上。微創手術、機器人輔助手術和其他創新技術正在湧現，使得介入措施更加安全、快速。

擴大門診手術中心

日間手術中心 (ASC) 具有諸多優勢，例如成本效益高、患者住院時間短以及降低醫院內感染風險。根據美國健康產業分銷商協會 (HSD) 的資料，2023 年 6 月，ACS 患者數量超過 12 億，較疫情前增加 13%。吸入麻醉因其起效快、恢復快的特點，非常適合 ASC 的需求。在 ASC 接受各種手術的患者選擇吸入麻醉，因為它可以快速恢復。此外，吸入麻醉術後噁心嘔吐的發生率較低，因此在日間手術環境中尤其重要。隨著越來越多的 ASC 需要滿足日益成長的門診手術服務需求，吸入麻醉市場正經歷大幅成長。這也促使生產商研發出專為 ASC 環境設計的使用者友善行動麻醉輸送設備。

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 二手資料
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球吸入麻醉市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依產品

  • 地氟烷
  • 七氟醚
  • 異氟烷
  • 其他

第7章：市場區隔：依應用

  • 就職
  • 維護

第 8 章：市場區隔：依最終用戶

  • 醫院
  • 門診手術中心
  • 其他

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第 10 章：SWOT 分析

第 11 章：價值鏈分析

第 12 章：波特五力分析

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbvie Inc.
    • Baxter International Inc.
    • Fresenius SE & Co. KGaA
    • Halocarbon Products Corporation
    • Hikma Pharmaceuticals PLC
    • Lunan Pharmaceutical Group Co. Ltd
    • Merck KGaA
    • Piramal Enterprises Ltd.
    • Troikaa Pharmaceuticals Ltd
Product Code: SR112025A3998

The global inhalation anesthesia market size reached USD 1.68 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.20 Billion by 2033, exhibiting a growth rate (CAGR) of 2.75% during 2025-2033. North America currently dominates the market, holding a market share of 52.8% in 2024. The growing number of people experiencing chronic medical conditions, along with collaborations among pharmaceutical firms, medical device companies, and healthcare institutions, is driving the market forward. Besides this, inhalation anesthesia market share is benefiting from the rising investments in advanced equipment by governments and private healthcare providers.

Increased government investments in healthcare facilities enhance access to surgical care and modern anesthetic technologies. Construction of new hospitals and surgical centers improves the availability of advanced inhalation anesthetic systems. Training programs for anesthesiologists in developing countries bolster the adoption of safe and effective anesthetics. Rising medical tourism in countries like India and Thailand increases the demand for inhalation anesthesia services. Advanced surgical procedures in emerging markets increases the use of modern anesthetic agents like sevoflurane and desflurane. Expanding health insurance coverage improves affordability and access to surgical treatments requiring inhalation anesthesia. Public-private partnerships (PPP) in healthcare projects promote the integration of advanced anesthetic technologies in underserved areas.

Innovative anesthesia machines allow precise monitoring and controlled delivery of inhalation anesthetics during surgical procedures. Improved pharmacokinetics of agents like sevoflurane enable rapid induction and faster post-operative recovery times. Integrated software systems in anesthesia machines enhance workflow efficiency and reduce risks of human error. Non-invasive monitoring technologies ensure real-time feedback on patient vitals, optimizing anesthesia administration and patient safety. Portable and compact anesthesia devices are increasingly utilized in outpatient settings and ambulatory surgical centers. Development of environmentally friendly anesthetic agents reduces the environmental impact of traditional inhalation anesthetics. Advancements in pediatric and geriatric anesthesia techniques cater to specialized healthcare needs in vulnerable populations. Telemedicine and remote monitoring tools support anesthetic care in underserved and rural areas. Artificial intelligence (AI) integration in anesthesia planning aids in personalized dosing and predictive patient outcome models. In May 2024, Panoramic Health launched a state-of-the-art ambulatory surgery center (ASC) in Tampa, Florida. The new center aims to provide high-quality, efficient outpatient surgical services for various medical procedures. Equipped with the latest technologies, the facility ensures precision, safety, and improved patient outcomes during surgeries.

Inhalation Anesthesia Market Trends:

Continual advancements in anesthetic agents and delivery systems

Pharmaceutical companies and medical device manufacturers are heavily investing in research and development (R&D) to create more effective and safer anesthetic gases and vapors. These innovations aim to enhance patient outcomes by reducing the risk of adverse effects and improving the overall anesthesia experience. Newer agents are being developed with improved pharmacokinetic profiles, enabling faster induction and emergence from anesthesia, thus shortening the time patients spend in the operating room. The most often used medication to induce general anesthesia is propofol (1 to 2.5 mg/kg IV). Furthermore, the development of sophisticated delivery systems, including precise vaporizers and monitoring technologies, ensures accurate administration and titration of anesthetic agents, minimizing the chances of over or under dosing. These advancements not only contribute to better patient care but also attract healthcare providers to adopt these modern solutions, thus impelling the inhalation anesthesia market growth.

Rising surgical procedures and patient volume

Population growth is normally associated with aging, which calls for increased numbers of surgical operations. The elderly generally require more operations because of conditions like heart diseases, replacements of joints, and treatments of cancer. Surgeon specialties including orthopedic, cardiology, oncology, and general surgery, require inhalation anesthesia for surgeries. Inhalation anesthesia becomes a preferred choice for these interventions because it produces immediate and controllable depth of sedation. It therefore constitutes a balance between the unconsciousness of the patient and stability of vitals. Additionally, the growth of medical knowledge and technology has stretched the scope of possible surgical interventions. As per the National Institute of Health in 2022, 53% of surgical patients were aged 65 years or older. Minimally invasive procedures, robotics-assisted surgeries, and other innovative techniques are emerging that allow for safer and quicker interventions.

Expansion of ambulatory surgical centers

Ambulatory surgical centers (ASCs) provide many benefits, such as cost-effectiveness, shorter patient stays, and reduced risk of hospital-acquired infections. ACS patient volumes exceeded 1.2 billion in June 2023, a 13% increase from pre-pandemic levels, based on data from the Health Industry Distributors Association. Inhalation anesthesia fits well with the needs of ASCs because of its rapid onset and quick recovery profile. Patients who present themselves for various procedures at ASCs opt for inhalation anesthesia because it offers quick recovery. Additionally, post-operative nausea and vomiting that occur after being under anesthesia are less in inhalation type, making it precious in an ambulatory setting. The market of inhalation anesthesia is experiencing substantial growth as more and more ASCs are required to meet the surging requirement of outpatient surgical services. It also encourages producers to create user-friendly and mobile anesthesia delivery devices designed for use in ASC settings.

Inhalation Anesthesia Industry Segmentation:

Analysis by Product:

  • Desflurane
  • Sevoflurane
  • Isoflurane
  • Others

Sevoflurane is the leading market with 56.0% market share in 2024. Based on the study, sevoflurane is gaining traction, and this is significantly attributed to the favorable pharmacokinetic profile. This agent allows for rapid induction so that anesthesiologists can guide the patient quickly and smoothly into and out of anesthesia. This, in turn, not only makes the process in the medical facilities more efficient but also ensures that patients face minimal delay in the onset and offset of surgical procedures. In addition, the low blood-gas solubility of sevoflurane enables equilibration between the lungs and the bloodstream very quickly, meaning quicker adjustments in the depth of anesthesia, consequently leading to quicker recoveries. This makes sevoflurane less likely to cause organ toxicity or compromise of vital functions and provides some level of reassurance to medical practitioners and patients alike. The safety profile has thus been crucial in making sevoflurane a staple of inhalation anesthesia practice, especially in pediatric and geriatric populations, where safety is of paramount importance.

Analysis by Application:

  • Induction
  • Maintenance

Maintenance dominates the market with 55.7% of market share in 2024. According to the report, maintenance ensuring patient comfort, surgical precision, and optimal outcomes. Once the patient is induced into anesthesia and the initial surgical incisions are made, maintaining the appropriate anesthetic depth becomes paramount. Anesthesia providers carefully titrate inhalation anesthetic agents to balance the patient's need for complete insensitivity to pain while avoiding over-sedation, which could lead to complications or lengthened recovery times. This dynamic balance requires continuous monitoring and adjustment throughout the procedure, highlighting the importance of skilled anesthesiologists. Moreover, the maintenance phase is directly linked to surgical efficacy and precision. Surgeons rely on patients being adequately anesthetized and immobilized to perform delicate procedures with accuracy. Any fluctuation in the anesthesia depth during the maintenance phase could lead to patient movement or awareness, potentially compromising the surgery's success.

Analysis by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Hospitals hold the largest market share with 67.8% of market share in 2024. Hospitals are a comprehensive healthcare provider that offer the full spectrum of medical services including routine surgeries, emergency interventions, and specialized procedures in various specialties. The sheer volume and variety of surgical interventions conducted in hospitals create a significant demand for anesthesia services. Inhalation anesthesia, which is capable of rapid induction and adjustable levels of sedation, fits seamlessly into the changing hospital operating rooms' environment. They are also equipped with advanced operating theaters, high technology monitoring systems, and experienced teams of anesthetists for handling a variety of cases. Such a well-established infrastructure allows the hospitals to effectively handle all the complexities arising with different kinds of surgeries that demand inhalation anesthesia. Besides, the fact that there exist separate units like pediatric and cardiac surgery departments within hospitals reflects the applicability of inhalation anesthesia to varied patient groups and different kinds of surgical interventions.

Regional Analysis

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2024, North America accounted for the largest market share of over 52.8%. North America is characterized by its emphasis on medical advancements and innovation. The presence of renowned research institutions, academic medical centers, and cutting-edge pharmaceutical companies fosters an environment conducive to the development of new anesthetic agents, delivery methods, and monitoring technologies. For example, in April 2024, Commons Clinic invested $9.75 million in launching an advanced spine surgery center in the United States. The center will feature a next-generation ambulatory surgical platform designed to enhance surgical efficiency. This commitment to innovation not only enhances patient care but also attracts healthcare professionals to adopt state-of-the-art anesthesia practices, including inhalation anesthesia techniques. The region's regulatory landscape and adherence to stringent safety standards further contribute to its dominance. Regulatory agencies such as the US Food and Drug Administration (FDA) play a pivotal role in ensuring the safety and efficacy of anesthesia agents and equipment. This rigorous oversight augments the confidence of healthcare providers and patients in the use of inhalation anesthesia, solidifying North America's position as a leader in the field. Also, North America's focus on medical education and training ensures that anesthesia providers are well-equipped to administer inhalation anesthesia safely and efficiently.

Key Regional Takeaways:

United States Inhalation Anesthesia Market Analysis

The United States hold 84.80% of the market share in North America. The main factors driving the inhalation anesthesia market demand in the United States are the increasing count of surgical procedures, the aging population, and improvements in healthcare infrastructure. According to paper published in ResearchGate, nearly 310 million major surgeries are conducted every year, with a big share going to the United States due to its developed healthcare system and high demand for surgery. According to the American Heart Association, over 121 million people suffering from chronic conditions that include cardiovascular disorders, which increases the demand for inhaled anesthesia systems, which can ensure safety, efficacy, of such anesthetic anesthesia delivery. The increasing demand for minimal invasive surgical practices, which boast shorter recovery time and fewer postoperative complications, further fuels this demand for inhalation anesthesia. Significant US manufacturers and increased interest in the need for balanced anesthesia also help propel the growth within the market.

Europe Inhalation Anesthesia Market Analysis

The market in Europe is driven by a robust healthcare system and the demographic of an ageing population. Europe has an aging population with 20% being 65 years or older as revealed by Eurostat. Long-term illnesses, such as cancer and neurological diseases require surgery hence, there is a considerable growth in demand for this medical procedure. More than 3.9 million cancer cases are reported in Europe, as per an industry report. Thus, it is important to have efficient solutions for anesthesia during surgeries. In addition, the European Union's emphasis on raising the healthcare standards and promoting minimally invasive surgical methods aids in market expansion. The government initiatives to enhance surgical treatment accessibility also increases the demand for inhalation anesthetics, such as desflurane and isoflurane. The extensive surgery volume and state-of-the-art medical facilities in countries like Germany, France, and the UK make them major contributors.

Asia Pacific Inhalation Anesthesia Market Analysis

Increasing populations, demand for surgeries, and healthcare infrastructural development drive the market for inhalation anesthesia in the Asia-Pacific. According to reports growing population with surgery demands in a country like China and India, comprising more than 36% of world population. Along with this, growing chronic diseases burden, especially the among diabetic population and the risk of cardiovascular problems, are leading to more surgeries in the region. For instance, according to an industry report, China documented more than 4.8 million new cancer cases in 2022 alone, which is the driving factor to promote the demand for effective anesthesia. The market is therefore expanding due to the increasing medical tourism sites in countries like Malaysia, Singapore, and Thailand. Moreover, the increasing adoption of advanced anesthesia delivery systems and government initiatives to expand access to quality healthcare ensure the high adoption of inhalation anesthetics, such as halothane and sevoflurane.

Latin America Inhalation Anesthesia Market Analysis

Increasing surgical procedures and improvement in healthcare facilities are driving the market in Latin America. Based on the 2019 estimates from the Global Procedure Volume Tracker of LSI, the three procedure types with the greatest volume in Brazil, includes obstetrical and gynecological procedures (4.4 million); general surgical procedures (3.2 million); and aesthetic, dermatological and plastic surgery related procedures (1.7 million). Increasing trends of lifestyle-associated disorders, obesity, and other cardiovascular diseases accelerate the adoption rate of inhalation anesthetics due to heightened surgical needs. In countries like Costa Rica and Colombia, affordable surgical procedures attract the inflow of patients from overseas. Medical tourism is also picking up in these regions. Additional incentives are emerging due to this region's heightened emphasis on improving safety when utilizing anesthesia and incorporating advanced technologies for its administration. Additionally, collaborations between global medical technology firms and local healthcare providers facilitate access to high-quality anesthesia products.

Middle East and Africa Inhalation Anesthesia Market Analysis

Growing investments in healthcare infrastructure and increased focus on surgical treatment are fueling the market growth in the Middle East and Africa. The Gulf Cooperation Council (GCC) countries including the United Arab Emirates and Saudi Arabia, lead the region in modern surgical capabilities with more than 1.8 million surgeries in 2022, as per reports. The region is experiencing more cases of chronic diseases like diabetes and cancer, which requires surgical interventions. The modernization of healthcare systems is being made by governments by investing in cutting-edge anesthesia equipment. Increased access to surgical treatment is through international collaborations and assistance initiatives in Africa, hence rising the demand for inhalation anesthetics, such as halothane and isoflurane.

Competitive Landscape:

Pharmaceutical and medical device companies are heavily investing in research and development (R&D) to create advanced anesthetic agents, delivery systems, and monitoring technologies. Moreover, companies are frequently introducing new inhalation anesthesia products and equipment to cater to the evolving needs of healthcare providers and patients. These products often incorporate the latest technological advancements, such as more precise vaporizers, integrated monitoring systems, and user-friendly interfaces. Additionally, leading players are focusing on developing innovative technologies that enhance the administration and monitoring of inhalation anesthesia. This includes the integration of electronic medical records (EMR) systems, real-time data analysis, and remote monitoring capabilities to ensure optimal patient care and safety. Additionally, numerous companies are providing training and educational programs to healthcare professionals, including anesthesiologists, nurse anesthetists, and operating room staff. These programs help ensure that healthcare providers are well-versed in the latest techniques, technologies, and safety measures related to inhalation anesthesia.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Abbvie Inc.
  • Baxter International Inc.
  • Fresenius SE & Co. KGaA
  • Halocarbon Products Corporation
  • Hikma Pharmaceuticals PLC
  • Lunan Pharmaceutical Group Co. Ltd
  • Merck KGaA
  • Piramal Enterprises Ltd.
  • Troikaa Pharmaceuticals Ltd.

Key Questions Answered in This Report

  • 1.How big is the inhalation anesthesia market?
  • 2.What is the future outlook of inhalation anesthesia market?
  • 3.What are the key factors driving the inhalation anesthesia market?
  • 4.Which region accounts for the largest inhalation anesthesia market share?
  • 5.Which are the leading companies in the global inhalation anesthesia market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Inhalation Anesthesia Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Desflurane
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Sevoflurane
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Isoflurane
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Induction
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Maintenance
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgical Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbvie Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Baxter International Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Fresenius SE & Co. KGaA
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Halocarbon Products Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Hikma Pharmaceuticals PLC
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Lunan Pharmaceutical Group Co. Ltd
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Merck KGaA
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Piramal Enterprises Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Troikaa Pharmaceuticals Ltd
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio

List of Figures

  • Figure 1: Global: Inhalation Anesthesia Market: Major Drivers and Challenges
  • Figure 2: Global: Inhalation Anesthesia Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Inhalation Anesthesia Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Inhalation Anesthesia Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Inhalation Anesthesia Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Inhalation Anesthesia Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Inhalation Anesthesia Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Inhalation Anesthesia (Desflurane) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Inhalation Anesthesia (Desflurane) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Inhalation Anesthesia (Sevoflurane) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Inhalation Anesthesia (Sevoflurane) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Inhalation Anesthesia (Isoflurane) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Inhalation Anesthesia (Isoflurane) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Inhalation Anesthesia (Other Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Inhalation Anesthesia (Other Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Inhalation Anesthesia (Induction) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Inhalation Anesthesia (Induction) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Inhalation Anesthesia (Maintenance) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Inhalation Anesthesia (Maintenance) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Inhalation Anesthesia (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Inhalation Anesthesia (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Inhalation Anesthesia (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Inhalation Anesthesia (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Inhalation Anesthesia (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Inhalation Anesthesia (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: North America: Inhalation Anesthesia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: North America: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: United States: Inhalation Anesthesia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: United States: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Canada: Inhalation Anesthesia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Canada: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Asia-Pacific: Inhalation Anesthesia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Asia-Pacific: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: China: Inhalation Anesthesia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: China: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Japan: Inhalation Anesthesia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Japan: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: India: Inhalation Anesthesia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: India: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: South Korea: Inhalation Anesthesia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: South Korea: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Australia: Inhalation Anesthesia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Australia: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Indonesia: Inhalation Anesthesia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Indonesia: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Others: Inhalation Anesthesia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Others: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Europe: Inhalation Anesthesia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Europe: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Germany: Inhalation Anesthesia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Germany: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: France: Inhalation Anesthesia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: France: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: United Kingdom: Inhalation Anesthesia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: United Kingdom: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Italy: Inhalation Anesthesia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Italy: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Spain: Inhalation Anesthesia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Spain: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Russia: Inhalation Anesthesia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Russia: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Others: Inhalation Anesthesia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Others: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Latin America: Inhalation Anesthesia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Latin America: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Brazil: Inhalation Anesthesia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Brazil: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Mexico: Inhalation Anesthesia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Mexico: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Inhalation Anesthesia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Middle East and Africa: Inhalation Anesthesia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Middle East and Africa: Inhalation Anesthesia Market: Breakup by Country (in %), 2024
  • Figure 74: Middle East and Africa: Inhalation Anesthesia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Global: Inhalation Anesthesia Industry: SWOT Analysis
  • Figure 76: Global: Inhalation Anesthesia Industry: Value Chain Analysis
  • Figure 77: Global: Inhalation Anesthesia Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Inhalation Anesthesia Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Inhalation Anesthesia Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Inhalation Anesthesia Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Inhalation Anesthesia Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Inhalation Anesthesia Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Inhalation Anesthesia Market: Competitive Structure
  • Table 7: Global: Inhalation Anesthesia Market: Key Players